A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France
Clinical trial NCT07451002 · RECRUITING
Trial details
- NCT number
- NCT07451002
- Sponsor
- Janssen Cilag S.A.S.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-18
- Primary completion
- 2028-01-03
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.